Sotera Health Company (SHC) Revenue History
Annual and quarterly revenue from 2018 to present
SHC Revenue Over Time (2018–2025)
SHC Revenue Growth History
7 of 7 years with positive growth- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- +4.3%
- FY2020 revenue growth
- +5.1%
- FY2021 revenue growth
- +13.9%
- FY2022 revenue growth
- +7.8%
- FY2023 revenue growth
- +4.5%
- FY2024 revenue growth
- +4.9%
- FY2025 revenue growth
- +5.7%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $280.0M | +10.0% |
| Q4 2025 | $303.4M | +4.6% |
| Q3 2025 | $311.3M | +9.1% |
| Q2 2025 | $294.3M | +6.4% |
| Q1 2025 | $254.5M | +2.6% |
| Q4 2024 | $290.2M | -6.5% |
| Q3 2024 | $285.5M | +8.5% |
| Q2 2024 | $276.6M | +8.3% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
SHC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
SHC Revenue Analysis (2018–2025)
Current Revenue & Growth
As of June 22, 2026, Sotera Health Company (SHC) generated trailing twelve-month (TTM) revenue of $1.19 billion, reflecting strong growth of +10.0% year-over-year. The most recent quarter (Q1 2026) recorded $280.0 million in revenue, down 7.7% sequentially.
Historical Growth Trajectory
SHC's 5-year compound annual growth rate (CAGR) stands at +7.3%, indicating steady revenue expansion. The 3-year CAGR of +5.1% is below the 5-year average, signalling a growth deceleration in recent years. Sotera Health Company's highest annual revenue of $1.16 billion was recorded in 2025, an all-time high.
Revenue by Segment
SHC's revenue is primarily driven by Service (86%), and Product (14%). With over half of revenue concentrated in Service, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including STRL (+37.0% YoY), ICLR (-1.3% YoY), and CRL (+0.1% YoY) — SHC has outperformed the peer group in revenue growth. Compare SHC vs STRL →
SHC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SHCCurrent | $1.2B | +10.0% | +7.3% | 33.8% | |
 STRL | $2.5B | +37.0% | +15.2% | 16.6% | |
 ICLR | $8.3B | -1.3% | +24.2% | 12.3% | |
 CRL | $4.0B | +0.1% | +6.5% | 12.6% | |
 MEDP | $2.5B | +24.2% | +22.3% | 21.1% | |
 PINC | $1.0B | -16.2% | -4.9% | 0.1% |
SHC Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.16B | +5.7% | $645.5M | 55.5% | $392.8M | 33.8% |
| 2024 | $1.10B | +4.9% | $602.3M | 54.7% | $297.6M | 27.0% |
| 2023 | $1.05B | +4.5% | $577.2M | 55.0% | $276.7M | 26.4% |
| 2022 | $1.00B | +7.8% | $557.0M | 55.5% | $248.3M | 24.7% |
| 2021 | $931.5M | +13.9% | $518.7M | 55.7% | $256.7M | 27.6% |
| 2020 | $818.2M | +5.1% | $443.6M | 54.2% | $206.0M | 25.2% |
| 2019 | $778.3M | +4.3% | $395.4M | 50.8% | $183.6M | 23.6% |
| 2018 | $746.1M | - | $357.3M | 47.9% | $80.8M | 10.8% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SHC — Frequently Asked Questions
Quick answers to the most common questions about buying SHC stock.
Is SHC's revenue growth accelerating or slowing?
SHC revenue growth is holding steady at +10.0% year-over-year. TTM revenue is $1.2B. The current growth rate closely tracks the 5-year CAGR of +7.3%, signalling consistent execution.
What is SHC's revenue history from 2018 to 2026?
Sotera Health Company (SHC) revenue history spans 2018 to 2026. TTM revenue as of 2026 is $1.2B, growing at +10.0% YoY. The 5-year CAGR is +7.3%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is SHC's long-term revenue growth rate (CAGR)?
Sotera Health Company's 5-year revenue CAGR of +7.3% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +10.0% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for SHC.
Why does SHC's quarterly revenue fluctuate?
SHC quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Sotera Health Company's revenue data from 2018 to 2026 shows full historical quarterly detail on this page.
How is SHC's revenue distributed by segment?
SHC reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does SHC's revenue compare to industry peers?
Sotera Health Company (SHC) with TTM revenue of $1.2B and +10.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.